Yeast cells expressing modified g proteins and methods of use therefor
Abstract
The present invention pertains to novel yeast cells which are useful for the expression of heterologous G protein coupled receptors. The yeast cells of the present invention can be used in screening assays which can be used to screen for modulators of G protein coupled receptors. Specifically, the invention provides novel yeast cells which express a heterologous G protein coupled receptor and mutant and/or chimeric G protein subunit molecules which serve to functionally integrate the heterologous into the pheromone signaling pathway of the yeast cell. The invention also provides for the expression of heterologous G protein coupled receptors which are functionally integrated into the yeast cell membrane using a yeast α factor leader sequence. Drug discovery assays using the subject yeast cells are also provided.
Claims
exact text as granted — not AI-modified1 - 18 . (canceled)
19 . A yeast cell comprising a first chimeric G protein subunit, said chimeric G protein subunit comprising a first polypeptide from a yeast G protein subunit and a second polypeptide from a heterologous G protein subunit, wherein said first polypeptide is selected from the group consisting of:
a polypeptide comprising about 40 amino acids from the amino terminus of yeast GPA1; and a polypeptide from yeast STE 18; and a second chimeric G protein subunit, said second chimeric G protein subunit comprising a first polypeptide from a yeast G protein subunit and a second polypeptide from a mammalian G protein subunit, wherein said second chimeric G protein subunit is different from said first chimeric G protein subunit.
20 . The yeast cell of claim 19 , wherein said second polypeptide of said second chimeric G protein subunit is from a protein selected from the group consisting of: a mammalian Gα subunit, a mammalian Gβ subunit, and a mammalian Gγ subunit.
21 - 25 . (canceled)
26 . An assay to identify compounds capable of modulating the dissociation of Gα and Gβγ, comprising the steps of:
(i) providing a yeast cell comprising:
(a) a heterologous G Protein coupled receptor, which receptor is functionally integrated into the yeast cell; and
a chimeric G Protein subunit, said chimeric G protein subunit comprising a first polypeptide from a yeast G protein subunit and a second polypeptide from a heterologous G protein subunit, wherein said first polypeptide is selected from the group consisting of a polypeptide comprising about 40 amino acids from the amino terminus of yeast GPA1 and a polypeptide from yeast STE 18; or
(b) (i) a heterologous G protein coupled receptor;
(ii) a non-naturally occurring G protein subunit which comprises a sequence from a heterologous G protein subunit in which at least one amino acid substitution has been introduced compared to the wild type sequence; such that expression of said non-naturally occurring G protein subunit functionally integrates said heterologous G protein coupled receptor into the yeast cell pheromone signaling pathway; and
(iii) an indicator gene that produces a detectable signal upon functional coupling of the heterologous G Protein coupled receptor to the G protein;
(ii) contacting the yeast with a test compound; and (iii) identifying compounds which induce a change in a detectable signal in the yeast cell, wherein said detectable signal indicates dissociation of Gα and Gβγ.
27 . The assay of claim 26 , wherein said test compound is from a library of non-peptidic organic molecules.
28 . A method for identifying a compound which modulates a heterologous G protein coupled receptor, comprising:
(i) providing a first, second, third, and fourth yeast cell, each cell comprising:
(a) a G protein, wherein:
1) the first yeast cell comprises a first chimeric G protein subunit comprising a first polypeptide from a yeast G protein subunit and a second polypeptide from a mammalian G protein subunit;
2) the second yeast cell comprises a second chimeric G protein subunit comprising a first polypeptide, derived from a yeast G protein subunit and a second polypeptide from a mammalian G protein subunit, said second chimeric G protein subunit being different from said first chimeric G protein subunit;
3) the third yeast cell comprises a third chimeric G protein subunit comprising a first polypeptide from a yeast G protein subunit and a second polypeptide from a mammalian G protein subunit, said third chimeric G protein subunit being different from said first and second chimeric G protein subunits; and
4) the fourth yeast cell comprises an endogenous yeast gpa1 G protein subunit;
(b) an expressible gene construct encoding a heterologous G protein coupled receptor (GPCR) which couples to the yeast pheromone system pathway; and
(c) an indicator gene that produces a change in a detectable signal upon functional coupling of the heterologous GPCR with the G protein;
(ii) contacting the first, second, third, and fourth yeast cells with a test compound; and (iii) determining whether the test compound induces a change in a detectable signal in at least one of the first, second, third, or fourth yeast cells to thereby identify a compound which modulates a heterologous GPCR.
29 . The assay of claim 28 , wherein at least one of said first, second, or third yeast cells comprises a fourth chimeric G protein subunit, said fourth chimeric G protein subunit being different from the first, second, or third chimeric G protein subunit expressed by the first, second, or third yeast cell, respectively.
30 . The assay of claim 28 , wherein at least one of said first, second, or third chimeric G proteins comprises a first polypeptide from yeast GPA1 and a second polypeptide from a mammalian G protein α-subunit.
31 . The assay of claim 30 , wherein said second polypeptide is from a mammalian Gαi subunit.
32 . The assay of claim 30 , wherein said second polypeptide is from a mammalian Gα16 subunit.
33 . The assay of claim 30 , wherein said second polypeptide is from a mammalian Gαs subunit.
34 . The assay of claim 28 , wherein the first chimeric G protein subunit comprises a polypeptide from mammalian Gα12, the second chimeric G protein subunit comprises a polypeptide from mammalian Gα16, and the third chimeric G protein subunit comprises a polypeptide from mammalian Gαs.
35 . The assay of claim 34 , wherein the second chimeric G protein subunit comprises Gα16(S270P) and the third chimeric G protein subunit comprises Gαs(D229S).
36 . The assay of claim 28 , wherein each of said first, second, and third yeast cells further comprises a fourth chimeric G protein subunit, said fourth chimeric G protein subunit comprising a first polypeptide from yeast STE 18 and a second polypeptide from a mammalian G protein y subunit.
37 . The assay of claim 28 , wherein the first, second, third, and fourth yeast cells are contacted with each member of a library of test compounds.
38 . The assay of claim 36 , wherein each member of said library is a non-peptidic organic molecule.
39 . The assay of claim 28 , wherein said first, second, third, and fourth yeast cells are Saccharomyces cerevisiae cells.
40 . The assay of claim 28 , wherein the indicator gene that gives rise to a detectable signal is selected from the group consisting of: β galactosidase, alkaline phosphatase, horseradish peroxidase, exoglucanase, luciferase, BAR1, PHO5, green fluorescent protein, and chloramphenicol acetyl transferase.
41 . The assay of claim 28 , wherein the indicator gene that gives rise to a detectable signal is selected from the group consisting of: HIS 3, β galactosidase, and green fluorescent protein.
42 . The assay of claim 28 , wherein said heterologous G protein coupled receptor is an orphan receptor.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.